"Chemokine CCL4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC chemokine with specificity for CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES and a variety of other immune cells. This chemokine is encoded by multiple genes.
| Descriptor ID |
D054407
|
| MeSH Number(s) |
D12.644.276.374.200.110.200 D12.644.276.374.200.600.200 D12.776.467.374.200.110.200 D12.776.467.374.200.600.200 D23.125.300.110.200 D23.125.300.600.750 D23.469.200.110.200 D23.529.374.200.110.200 D23.529.374.200.600.200
|
| Concept/Terms |
Chemokine CCL4- Chemokine CCL4
- CCL4, Chemokine
- Macrophage Inflammatory Protein 1-beta
- Macrophage Inflammatory Protein 1 beta
- MIP-1beta
- MIP 1beta
- CCL4 Chemokine
- Chemokine, CCL4
Chemokine CCL4L1- Chemokine CCL4L1
- CCL4L1, Chemokine
- Macrophage Inflammatory Protein-1beta2
- Inflammatory Protein-1beta2, Macrophage
- Macrophage Inflammatory Protein 1beta2
- CCL4L1 Chemokine
- Chemokine, CCL4L1
Chemokine CCL4L2- Chemokine CCL4L2
- CCL4L2, Chemokine
- CCL4L2 Chemokine
- Chemokine, CCL4L2
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL4".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL4".
This graph shows the total number of publications written about "Chemokine CCL4" by people in this website by year, and whether "Chemokine CCL4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL4" by people in Profiles.
-
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019 12; 5(12):eaay1357.
-
Structures of human CCL18, CCL3, and CCL4 reveal molecular determinants for quaternary structures and sensitivity to insulin-degrading enzyme. J Mol Biol. 2015 Mar 27; 427(6 Pt B):1345-1358.
-
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO J. 2010 Dec 01; 29(23):3952-66.
-
Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J Virol. 2005 Jun; 79(12):7889-98.
-
Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology. 2002 Mar; 122(3):725-33.
-
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J Neurovirol. 1999 Dec; 5(6):635-42.
-
Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS. AIDS. 1998 Mar 05; 12(4):399-409.
-
lin-12 and glp-1 are required zygotically for early embryonic cellular interactions and are regulated by maternal GLP-1 signaling in Caenorhabditis elegans. Development. 1996 Dec; 122(12):4105-17.